Canada vs Eastern Mediterranean (WHO region): Treatment success rate: XDR-TB cases
Canada
100
in 2013
Eastern Mediterranean (WHO region)
74
in 2022
Canada rank
1st
Eastern Mediterranean (WHO region) rank
1st
Treatment success rate: XDR-TB cases over time
- Canada
- Eastern Mediterranean (WHO region)
How they compare
Canada currently reports 100 against 74 in Eastern Mediterranean (WHO region), a difference of 26.
That makes Canada's figure about 1.4 times Eastern Mediterranean (WHO region)'s.
The two have swapped places 2 times across 5 shared years of data; in 2008 it was Canada ahead.
Canada ranks 1st and Eastern Mediterranean (WHO region) ranks 1st of 82 countries.
Canada has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Canada | Eastern Mediterranean (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100 | 0 | 100 | Canada |
| 2010s | 75 | 36.5 | 38.5 | Canada |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate: xdr-tb cases, Canada or Eastern Mediterranean (WHO region)?
- Canada, at 100 against 74 in Eastern Mediterranean (WHO region) as of 2013.
- What is the difference in treatment success rate: xdr-tb cases between Canada and Eastern Mediterranean (WHO region)?
- 26, with Canada ahead.
- How many years of comparable data are there for Canada and Eastern Mediterranean (WHO region)?
- 5 years are reported by both, from 2008 to 2013.
- How do Canada and Eastern Mediterranean (WHO region) rank globally for treatment success rate: xdr-tb cases?
- Canada ranks 1st and Eastern Mediterranean (WHO region) ranks 1st of 82 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate: XDR-TB cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.